Health Catalyst (HCAT) news
Recent news
Health Catalyst, Inc.: Canaccord Genuity cuts to hold from buy; cuts target price to $1.8 from $3
AInvest Wire · Aug 21, 2026Health Catalyst Inc FY2026 rev view $260.8 mln -- LSEG IBES data
Health Catalyst Inc. (Nasdaq: HCAT) reported first-quarter 2026 financial results on May 11, 2026, with total revenue of $70.756 million, a 11% decline compared to $79.413 million in the same period in 2025. The company provided updated guidance for the full year of 2026, projecting total revenue…
AInvest Wire · Aug 6, 2026Health Catalyst Inc Q3 rev view $62.2 mln -- LSEG IBES data
AInvest Wire · Aug 6, 2026Health Catalyst - guides FY2026 revenue $246 mln-$249 mln
AInvest Wire · Aug 6, 2026Health Catalyst outlook Q3 revenue USD 55-56 million
Health Catalyst, Inc. (Nasdaq: HCAT) reported its third-quarter 2023 financial results on November 2, 2023, highlighting total revenue of $73.8 million , surpassing the mid-point of its quarterly guidance for both total revenue and Adjusted EBITDA. The company’s CEO, Dan Burton, expressed…
AInvest Wire · Aug 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.